Concepedia

Vladimir Janković

VJ

Statistics

Publications

6

Citations

398

H-Index

6

Active since

2000

Affiliations

Bristol-Myers Squibb (Switzerland)(Current)

Czech Academy of Sciences, Institute of Microbiology

Institute for Biological Sciences

Memorial Sloan Kettering Cancer Center

University of Belgrade

Vladimir Janković is an author at Bristol-Myers Squibb (Switzerland) specializing in cell biology, inflammation, and medicine.

ORCID

Top concepts

Publications per year

2000–2017

6

Publications

6

Methylation of RUNX1 by PRMT1 abrogates SIN3A binding and potentiates its transcriptional activity

Xinyang Zhao, Vladimir Janković, Alexander Gural et al. · Genes & Development · 2008 · 183 citations · Full text

AML1-ETO fusion protein up-regulates TRKA mRNA expression in human CD34<sup>+</sup>cells, allowing nerve growth factor-induced expansion

James C. Mulloy, Vladimir Janković, Mark Wunderlich et al. · Proceedings of the National Academy of Sciences · 2005 · 67 citations · Full text

STAT1 IS REQUIRED FOR iNOS ACTIVATION, BUT NOT IL-6 PRODUCTION IN MURINE FIBROBLASTS

Tatjana Samardžić, Vladimir Janković, Stanislava Stošić‐Grujičić et al. · Cytokine · 2001 · 42 citations

, , +7

Human Placenta-Derived Mesenchymal Stromal-Like Cells Enhance Angiogenesis via T Cell-Dependent Reprogramming of Macrophage Differentiation

Shuyang He, Joseph Gleason, Ewa Fik-Rymarkiewicz et al. · Stem Cells · 2017 · 42 citations · Full text

Safety and efficacy of intramuscular human placenta‐derived mesenchymal stromal‐like cells (cenplacel [PDA‐002]) in patients who have a diabetic foot ulcer with peripheral arterial disease

Stephanie Wu, Richard Pollak, Robert G. Frykberg et al. · International Wound Journal · 2017 · 33 citations · Full text

1–5 of 6